Table 1.
Cytotoxic activity of thioalbamide in comparison to doxorubicin a.
Cell Line | Doxorubicin | Thioalbamide | |
---|---|---|---|
MCF7 b | IC50 (μM) | 0.878 | 0.059 |
95% confidence interval | 0.723 to 1.071 | 0.049 to 0.072 | |
MDA-MB-231 b | IC50 (μM) | 1.174 | 0.072 |
95% confidence interval | 0.938 to 1.477 | 0.058 to 0.088 | |
MDA-MB-468 | IC50 (μM) | 0.362 | 0.054 |
95% confidence interval | 0.259 to 0.504 | 0.043 to 0.069 | |
T47D | IC50 (μM) | 0.536 | 0.075 |
95% confidence interval | 0.380 to 0.756 | 0.061 to 0.092 | |
SKBR3 | IC50 (μM) | 0.154 | 0.074 |
95% confidence interval | 0.108 to 0.221 | 0.056 to 0.097 | |
MCF 10A b | IC50 (μM) | 0.343 | 0.302 |
95% confidence interval | 0.253 to 0.464 | 0.206 to 0.444 | |
BJ-hTERT | IC50 (μM) | 0.360.5 | 0.321 |
95% confidence interval | 0.269 to 0.484 | 0.215 to 0.474 |
a Data are presented as IC50 values (μM) and 95% confidence intervals obtained by nonlinear regression analysis of three independent experiments. b Results reported in [1].